Melinta Therapeutics Inc (MLNTQ)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: MLNTQ Exchange: OTC


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-07-02 2019-06-27 S Sale

JOHNSON JOHN

Chief Executive Officer

Executive Director
13,000 -25.8%
5.57
USD 72,441 		13,000 -25.8% 5.57 USD 72,441
2018-05-31 2018-05-29 B Purchase

Duffy Erin

Chief Scientific Officer

Officer
4,000 +inf%
5.00
USD 20,000 		4,000 +inf% 5.00 USD 20,000
2018-05-31 2018-05-29 B Purchase

ZACCARDELLI DAVID

Non-Executive Director
40,000 +615.4%
5.00
USD 200,000 		40,000 +615.4% 5.00 USD 200,000
2018-05-31 2018-05-29 B Purchase

Wechsler Daniel Mark

See Remarks

Executive Director
50,000 +inf%
5.00
USD 250,000 		50,000 +inf% 5.00 USD 250,000
2018-05-31 2018-05-29 B Purchase

Cammarata Sue

Chief Medical Officer

Officer
4,000 +inf%
5.00
USD 20,000 		4,000 +inf% 5.00 USD 20,000
2018-05-31 2018-05-29 B Purchase

Estrem Paul

Chief Financial Officer

Officer
10,000 +inf%
5.00
USD 50,000 		10,000 +inf% 5.00 USD 50,000
2018-05-31 2018-05-29 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Large shareholder
7,878,500 +90.3%
5.00
USD 39,392,500 		7,878,500 +90.3% 5.00 USD 39,392,500
2018-05-31 2018-05-29 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Large shareholder
7,878,500 +90.3%
5.00
USD 39,392,500 		7,878,500 +90.3% 5.00 USD 39,392,500
2018-05-31 2018-05-29 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Large shareholder
7,500,000 +88.2%
5.00
USD 37,500,000 		7,500,000 +88.2% 5.00 USD 37,500,000
2018-05-30 2018-05-25 B Purchase

GILL DAVID N

Non-Executive Director
5,000 +500.0%
6.09
USD 30,450 		5,000 +500.0% 6.09 USD 30,450
2018-01-09 2018-01-05 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Large shareholder
2,000,000 +29.7%
13.50
USD 27,000,000 		2,000,000 +29.7% 13.50 USD 27,000,000
2018-01-09 2018-01-05 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Large shareholder
2,000,000 +29.7%
13.50
USD 27,000,000 		2,000,000 +29.7% 13.50 USD 27,000,000
2018-01-09 2018-01-05 B Purchase

Vatera Healthcare Partners LLC

Non-Executive Director Large shareholder
1,777,778 +26.4%
13.50
USD 24,000,003 		1,777,778 +26.4% 13.50 USD 24,000,003
2017-03-09 2017-03-08 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
99,900 -100.0%
3.57
USD 356,443 		99,900 -100.0% 3.57 USD 356,443
2017-03-09 2017-03-07 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
50,100 -33.4%
3.53
USD 176,673 		50,100 -33.4% 3.53 USD 176,673
2017-01-18 2017-01-13 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
105,460 -41.3%
3.40
USD 358,564 		105,460 -41.3% 3.40 USD 358,564
2017-01-06 2017-01-06 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
437,600 -63.1%
3.64
USD 1,592,864 		437,600 -63.1% 3.64 USD 1,592,864
2017-01-06 2017-01-05 S Sale

GOLDSTEIN DOV A MD

Non-Executive Director
500,000 -41.9%
3.20
USD 1,600,000 		500,000 -41.9% 3.20 USD 1,600,000
2017-01-04 2017-01-03 B Purchase

GILL DAVID N

Non-Executive Director
5,000 +inf%
2.94
USD 14,720 		5,000 +inf% 2.94 USD 14,720
2016-03-02 2016-03-01 B Purchase

Moore David

Chief Commercial Officer

Officer
500 +50.0%
16.18
USD 8,090 		500 +50.0% 16.18 USD 8,090
2016-01-06 2016-01-04 PS Planned sale

GOLDSTEIN DOV A MD

Non-Executive Director
842 -94.4%
30.06
USD 25,314 		842 -94.4% 30.06 USD 25,314
2015-12-15 2015-12-15 PS Planned sale

Oldach David W.

Chief Medical Officer

Officer
1,778 -61.8%
30.00
USD 53,340 		1,778 -61.8% 30.00 USD 53,340
2015-12-15 2015-12-11 PS Planned sale

Oldach David W.

Chief Medical Officer

Officer
8,222 -88.2%
30.33
USD 249,373 		8,222 -88.2% 30.33 USD 249,373
2015-11-12 2015-11-09 S Sale

Oldach David W.

Chief Medical Officer

Officer
2,200 -66.7%
28.78
USD 63,316 		2,200 -66.7% 28.78 USD 63,316
2015-11-12 2015-11-09 S Sale

Oldach David W.

Chief Medical Officer

Officer
10,000 -75.2%
28.78
USD 287,800 		10,000 -75.2% 28.78 USD 287,800
2015-10-27 2015-10-26 B Purchase

DOUGHERTY MICHAEL R

Non-Executive Director
2,000 +inf%
18.45
USD 36,896 		2,000 +inf% 18.45 USD 36,896
2015-10-26 2015-10-26 B Purchase

Kong Garheng

Non-Executive Director
2,830 +inf%
17.43
USD 49,335 		2,830 +inf% 17.43 USD 49,335
2015-06-24 2015-06-22 PS Planned sale

GOLDSTEIN DOV A MD

Non-Executive Director
50,000 -99.9%
35.74
USD 1,787,000 		50,000 -99.9% 35.74 USD 1,787,000
2015-05-27 2015-05-22 S Sale

Fernandes Prabhavathi

President and CEO

Executive Director
9,000 -3.5%
35.72
USD 321,489 		9,000 -3.5% 35.72 USD 321,489
2014-05-28 2014-05-23 B Purchase

JOHNSON JOHN

Non-Executive Director
10,000 +inf%
9.10
USD 90,980 		10,000 +inf% 9.10 USD 90,980
2013-08-01 2013-06-19 B Purchase

NEFF P SHERRILL

Non-Executive Director
265,000 +8.1%
7.00
USD 1,855,000 		265,000 +8.1% 7.00 USD 1,855,000
2013-08-01 2013-06-19 B Purchase

Quaker BioVentures II LP

Large shareholder
265,000 +8.1%
7.00
USD 1,855,000 		265,000 +8.1% 7.00 USD 1,855,000
2014-05-13 2013-05-09 B Purchase

Fernandes Prabhavathi

President and CEO

Executive Director
3,500 +1.7%
8.60
USD 30,100 		3,500 +1.7% 8.60 USD 30,100
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Large shareholder
1,025 +0.2%
6.00
USD 6,150 		1,025 +0.2% 6.00 USD 6,150
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Large shareholder
16,667 +3.5%
6.00
USD 100,002 		16,667 +3.5% 6.00 USD 100,002
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Large shareholder
1,025 +0.2%
6.00
USD 6,150 		1,025 +0.2% 6.00 USD 6,150
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Large shareholder
16,666 +3.6%
6.00
USD 99,996 		16,666 +3.6% 6.00 USD 99,996
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Large shareholder
1,025 +0.2%
6.00
USD 6,150 		1,025 +0.2% 6.00 USD 6,150
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Large shareholder
16,666 +3.3%
6.00
USD 99,996 		16,666 +3.3% 6.00 USD 99,996
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Large shareholder
1,025 +0.1%
6.00
USD 6,150 		1,025 +0.1% 6.00 USD 6,150
2012-02-10 2012-02-08 B Purchase

MORRIS I WISTAR III

Non-Executive Director Large shareholder
16,667 +2.3%
6.00
USD 100,002 		16,667 +2.3% 6.00 USD 100,002
2012-02-09 2012-02-08 B Purchase

Intersouth Associates VI, LLC

Large shareholder
732,989 +119.7%
6.00
USD 4,397,934 		732,989 +119.7% 6.00 USD 4,397,934
2012-02-09 2012-02-08 B Purchase

NEFF P SHERRILL

Non-Executive Director Large shareholder
1,189,805 +57.4%
6.00
USD 7,138,830 		1,189,805 +57.4% 6.00 USD 7,138,830
2012-02-09 2012-02-08 B Purchase

Intersouth Associates VI, LLC

Large shareholder
488,659 +33.0%
6.00
USD 2,931,954 		488,659 +33.0% 6.00 USD 2,931,954
2012-02-09 2012-02-07 B Purchase

Aisling Capital II LP

Large shareholder
1,213,663 +58.4%
6.00
USD 7,281,978 		1,213,663 +58.4% 6.00 USD 7,281,978
2012-02-09 2012-02-07 B Purchase

GOLDSTEIN DOV A MD

Non-Executive Director
1,213,663 +58.4%
6.00
USD 7,281,978 		1,213,663 +58.4% 6.00 USD 7,281,978
// ... existing code ... // ... rest of the file ...